Search

everythinglearnresearchcommunity

for

Search:↓

New findings explain how genetic changes, body clocks, and certain molecules affect tissue response to stress hormones.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Bisphenol-A (BPA) increases connections between brain cells and boosts their activity, but it blocks the effects of a male hormone on brain cell plasticity.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

Some plant-based treatments may help with ovary function, insulin resistance, and excess male hormones in PCOS, but more research is needed to confirm their safety and effectiveness.

Kidney stones form due to factors like urine concentration, calcium deposits, hormones, gut bacteria, and immune response.

Ringworm in pets is influenced by fungi type, immune status, and stress hormones.

Aldactone was more effective in reducing hair growth in women with hirsutism than Diane, despite having less impact on hormone levels.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Finasteride helps regrow hair and shrink prostate by reducing DHT, with some sexual side effects.

Certain immune molecules and stress affect hair loss, and while genes play a role, more research is needed to fully understand and treat it.

New dissolving and implantable microneedle patches have been created for a long-lasting, non-invasive delivery of the drug finasteride.

Minoxidil can reduce functions related to androgen receptors.

PCOS symptoms can improve with specific treatments for pituitary adenomas.

Alopecia in dogs requires identifying the cause for effective treatment.

Metal nanoparticles show promise for treating hair loss but need more research to ensure safety.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

Quercetin-loaded nanoparticles can penetrate skin, minimize hair loss, and promote hair regrowth, showing slightly better results than a marketed product.

IGF2BP3 and other m6A-related genes are linked to keloid formation and could be potential treatment targets.

Long-term use of azole antifungals can cause hair loss, hormonal imbalances, and severe skin reactions.

New therapies are being developed that target integrin pathways to treat various diseases.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Cyclodextrins improve finasteride's solubility and bioavailability for hair loss treatment.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

The study concluded that similar pathways regulate hair growth in dogs and mice, and these pathways are disrupted in dogs with Alopecia X, affecting stem cells and hormone metabolism.

A certain mutation in the fetal alpha 5-reductase gene is linked to a higher risk of late miscarriage.

The new topical growth hormone formula has high skin penetration and bioavailability.

Nanotechnology shows promise for treating hair loss but faces safety and approval challenges.

Targeting multiple pathways may improve treatments for androgenetic alopecia.

Using stem cells from hair follicles to treat female hair loss is safe and effective after six months.